214 related articles for article (PubMed ID: 31775395)
1. Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma.
Massimi M; Ragusa F; Cardarelli S; Giorgi M
Cells; 2019 Nov; 8(12):. PubMed ID: 31775395
[TBL] [Abstract][Full Text] [Related]
2. cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease.
Elnagdy M; Barve S; McClain C; Gobejishvili L
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33050657
[TBL] [Abstract][Full Text] [Related]
3. PDE4 subtypes in cancer.
Hsien Lai S; Zervoudakis G; Chou J; Gurney ME; Quesnelle KM
Oncogene; 2020 May; 39(19):3791-3802. PubMed ID: 32203163
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Development of Phosphodiesterase-4 Inhibitors.
Peng T; Qi B; He J; Ke H; Shi J
J Med Chem; 2020 Oct; 63(19):10594-10617. PubMed ID: 32255344
[TBL] [Abstract][Full Text] [Related]
5. Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq.
Liu X; Li J; Wang Q; Bai L; Xing J; Hu X; Li S; Li Q
Front Immunol; 2022; 13():1012303. PubMed ID: 36311759
[TBL] [Abstract][Full Text] [Related]
6. cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach.
Ahmed MB; Alghamdi AAA; Islam SU; Lee JS; Lee YS
Cells; 2022 Jun; 11(13):. PubMed ID: 35805104
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma.
Lu J; Chen Y; Zhang X; Guo J; Xu K; Li L
Cancer Cell Int; 2022 Jan; 22(1):38. PubMed ID: 35078458
[TBL] [Abstract][Full Text] [Related]
8. Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx.
Li L; Shen L; Ma J; Zhou Q; Li M; Wu H; Wei M; Zhang D; Wang T; Qin S; Xing T
Front Med (Lausanne); 2020; 7():451. PubMed ID: 33043022
[TBL] [Abstract][Full Text] [Related]
9. Myo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body Myositis.
De Paepe B; Merckx C; Jarošová J; Cannizzaro M; De Bleecker JL
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32235474
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a prognostic classifier based on HIF-1 signaling for hepatocellular carcinoma.
Deng F; Chen D; Wei X; Lu S; Luo X; He J; Liu J; Meng T; Yang A; Chen H
Aging (Albany NY); 2020 Feb; 12(4):3431-3450. PubMed ID: 32084009
[TBL] [Abstract][Full Text] [Related]
11. CD8
Chen Y; Xin Z; Huang L; Zhao L; Wang S; Cheng J; Wu P; Chai Y
Front Immunol; 2019; 10():3002. PubMed ID: 32010126
[No Abstract] [Full Text] [Related]
12. Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC).
Shen H; Wang Z; Ren S; Wang W; Duan L; Zhu D; Zhang C; Duan Y
Int Immunopharmacol; 2020 Apr; 81():106222. PubMed ID: 32007795
[TBL] [Abstract][Full Text] [Related]
13. Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx.
Steen CB; Liu CL; Alizadeh AA; Newman AM
Methods Mol Biol; 2020; 2117():135-157. PubMed ID: 31960376
[TBL] [Abstract][Full Text] [Related]
14. Advances in molecular classification and precision oncology in hepatocellular carcinoma.
Rebouissou S; Nault JC
J Hepatol; 2020 Feb; 72(2):215-229. PubMed ID: 31954487
[TBL] [Abstract][Full Text] [Related]
15. Phenotype molding of T cells in colorectal cancer by single-cell analysis.
Di J; Liu M; Fan Y; Gao P; Wang Z; Jiang B; Su X
Int J Cancer; 2020 Apr; 146(8):2281-2295. PubMed ID: 31901134
[TBL] [Abstract][Full Text] [Related]
16. Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches.
Tagliamonte M; Mauriello A; Cavalluzzo B; Ragone C; Manolio C; Petrizzo A; Buonaguro L
Cancer Lett; 2020 Mar; 473():25-32. PubMed ID: 31875523
[TBL] [Abstract][Full Text] [Related]
17. Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis.
Kakiuchi N; Yoshida K; Uchino M; Kihara T; Akaki K; Inoue Y; Kawada K; Nagayama S; Yokoyama A; Yamamoto S; Matsuura M; Horimatsu T; Hirano T; Goto N; Takeuchi Y; Ochi Y; Shiozawa Y; Kogure Y; Watatani Y; Fujii Y; Kim SK; Kon A; Kataoka K; Yoshizato T; Nakagawa MM; Yoda A; Nanya Y; Makishima H; Shiraishi Y; Chiba K; Tanaka H; Sanada M; Sugihara E; Sato TA; Maruyama T; Miyoshi H; Taketo MM; Oishi J; Inagaki R; Ueda Y; Okamoto S; Okajima H; Sakai Y; Sakurai T; Haga H; Hirota S; Ikeuchi H; Nakase H; Marusawa H; Chiba T; Takeuchi O; Miyano S; Seno H; Ogawa S
Nature; 2020 Jan; 577(7789):260-265. PubMed ID: 31853061
[TBL] [Abstract][Full Text] [Related]
18. Somatic inflammatory gene mutations in human ulcerative colitis epithelium.
Nanki K; Fujii M; Shimokawa M; Matano M; Nishikori S; Date S; Takano A; Toshimitsu K; Ohta Y; Takahashi S; Sugimoto S; Ishimaru K; Kawasaki K; Nagai Y; Ishii R; Yoshida K; Sasaki N; Hibi T; Ishihara S; Kanai T; Sato T
Nature; 2020 Jan; 577(7789):254-259. PubMed ID: 31853059
[TBL] [Abstract][Full Text] [Related]
19. Tumour evolution in hepatocellular carcinoma.
Craig AJ; von Felden J; Garcia-Lezana T; Sarcognato S; Villanueva A
Nat Rev Gastroenterol Hepatol; 2020 Mar; 17(3):139-152. PubMed ID: 31792430
[TBL] [Abstract][Full Text] [Related]
20. DeepKEGG: a multi-omics data integration framework with biological insights for cancer recurrence prediction and biomarker discovery.
Lan W; Liao H; Chen Q; Zhu L; Pan Y; Chen YP
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38678587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
